Cancer Screening Tests
Conditions
Keywords
decision aid, cancer screening, risk assessment, risk communication, colorectal neoplasm, decision making
Brief summary
Precision prevention holds great promise for colorectal cancer (CRC) screening but has not been adequately explored. A patient's chance of having an advanced colorectal neoplasm (ACN), i.e. a cancer or precancerous polyp in the colon, significantly affects the comparative effectiveness of approved tests. Giving patients a decision aid with information about their risk for ACN, and giving their providers similar information, could help patients and providers decide if colonoscopy or a non-invasive test (such as the fecal immunochemical test) is more appropriate. This could improve decision making and increase uptake of CRC screening, which are the investigative team's long-term goals.
Detailed description
The research team has developed and pilot tested a decision aid and provider message that discloses the patient's current risk of ACN, based on a prediction rule developed and validated by Dr. Thomas Imperiale, a member of the study team. The Imperiale Prediction Rule uses five variables (gender, age, CRC family history, waist circumference, and smoking history) and identifies a wide range of risk for current ACN among average risk patients. For patients with high-average risk (22%), personalized messages in the decision aid and provider notification highlight the advantage of colonoscopy because of the likelihood of finding and removing an ACN. For patients at low risk for ACN (2% or 4%), personalized messages highlight the advantage of stool testing, due to the relatively low chance of failing to detect ACN. The investigators' long-term goal is to increase uptake of CRC screening by informing and improving patient and provider discussion and decisions. The main objective of this project is to test whether providing patients and their providers with personalized messages about ACN risk results in higher screening uptake and higher decision quality, compared to an approach that does not utilize ACN risk.
Interventions
BEHAVIORALDecision aid without personalized message
The decision aid without personalized message consists of a PowerPoint presentation converted to mp4 (video) with text, photos, and an audio track, that is advanced by the viewer and can be viewed online. It begins with a 60 sec video on CRC screening produced by the Centers for Disease Control and Prevention (CDC), followed by slides summarizing the advantages and disadvantages of colonoscopy and stool testing with the fecal immunochemical test (FIT) and DNA+FIT (Cologuard). The presentation is approximately 10 minutes long.
BEHAVIORALDecision aid with personalized message
The decision aid with personalized message will first present the decision aid without personalized message followed by additional PowerPoint slides converted to mp4 (video) with text, photos, and an audio track briefly explaining the risk tool, the participant's score on the 5 risk factors, total score, ACN risk, and implications for screening and test choice. The presentation is approximately 14 minutes long.
BEHAVIORALProvider notification without personalized message
Providers will receive a message informing them that their enrolled patient is due for CRC screening. The notification will be sent to them through the electronic health record (EHR) within 24 hours of their visit with the enrolled patient.
BEHAVIORALProvider notification with personalized message
Providers will receive a message informing them that their enrolled patient is due for CRC screening. The notification will also include the patient's ACN risk (very low, low, moderate, high-average) and implications for screening decisions and test choice. Links to a web landing page containing a more detailed explanation of the risk tool and additional references will be included. The notification will be sent to them through the electronic health record (EHR) within 24 hours of their visit with the enrolled patient.
Sponsors
Patient-Centered Outcomes Research Institute
Indiana University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
SINGLE (Subject)
Masking description
Provider-participants will know that their enrolled patient-participant is participating in the study but will not know what arm they were assigned.
Intervention model description
2x2, randomized, controlled trial
Eligibility
Sex/Gender
ALL
Age
50 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
PATIENTS will be eligible if they are: * age 50 - 75 years * have not had a colonoscopy performed in the last 10 years, sigmoidoscopy in the last 5 years, fecal occult blood testing (FOBT or FIT) in the last year, or Cologuard in the last 3 years * have not had a colonoscopy since turning 50 years old * have a scheduled appointment with a provider who agreed to participate in the study PROVIDERS will be eligible if they are: * a physician (MD or DO), nurse practitioner (NP), or physicians assistant (PA) practicing at a partner research site
Exclusion criteria
PATIENTS will be excluded if they are: * undergoing workup for symptoms consistent with CRC, such as unexplained weight loss, change in bowel habit, or rectal bleeding * have a diagnosis or medical history conferring elevated risk for CRC including a previous adenomatous polyp or CRC, inflammatory bowel disease, high-risk syndromes, or a significant family history of CRC (two or more first degree relatives (FDR) with CRC or one FDR with a CRC diagnosis prior to age 60) * are unable to speak and read English * previously participated in any research projects regarding colorectal cancer screening or colonoscopy including, but not limited to the investigators' previous studies * members of the study team will not be participating in the study; therefore, patients who have a scheduled appointment with any member of the study team will not be eligible. PROVIDERS will be excluded if they: * do not have patients between 50 - 75 years old.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants Who Completed Colorectal Cancer Screening | 6 months after patient enrollment | Patients' completion of colonoscopy, fecal immunochemical testing (FIT), or other CRC screening within 6 months, based on documentation in the participants' electronic health record. |
| Number of Participants Who Made a High Quality Decision Using the Multi-dimensional Measure of Informed Consent (MMIC) Which Incorporates Knowledge, Intent, and Behavior. | 6 months after participant enrollment | Decision quality will be assessed using the multi-dimensional measure of informed consent (MMIC), where a high-quality decision is one where the individual has adequate knowledge regarding the available options and undergoes the screening test that he or she has chosen or that fits his or her values (values concordance). Patient knowledge of colorectal cancer and screening will be assessed by a 12-item test made up of 6 multiple choice questions and 6 true-false questions. Adequate knowledge = 9 correct. Concordance will be measured between the patient's test choice at the post-provider survey and the screening test underwent, if any, within 6 months after patient enrollment. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | 1 day (immediately before viewing intervention [baseline/T1] and after viewing intervention [post-intervention/T1]); and approximately 4-30 days after viewing intervention and 4-14 days after provider visit (post-provider visit/T2) | For those patients who answer the screening intent item with definitely not, probably not, or may or may not, test choice will be categorized as no screening. Those who answer Screening Intent with Probably or Definitely have Test Choice categorized based on their answer to a single item: If you have a colon test, which one would you choose? Response options are: Stool test (FIT or Cologuard), Colonoscopy, Another test, or Don't know. |
| Average Correct Responses of Participants to Knowledge Questions About Colorectal Cancer (CRC) and CRC Screening: Change Between Baseline, Post-intervention, and Post-provider Visit. | 1 day (immediately before viewing intervention [baseline/T1] and after viewing intervention [post-intervention/T1]); and approximately 4-30 days after viewing intervention and 4-14 days after provider visit (post-provider visit/T2) | Knowledge was assessed with six multiple choice and six true/false questions regarding general information (including risk factors, screening test options, and test frequency) of CRC and CRC screening. Knowledge scores were derived by summing correct responses to the 12 individual knowledge questions (range, 0-12), and change was calculated from baseline (T0) to post-intervention (T1), post-intervention (T1) to post-provider visit (T2), and from baseline (T0) to post-provider (T2) by using the knowledge score at the later time point minus the knowledge score of the former time point. The range for change could be -12 to 12 with higher values meaning an increase in knowledge which is a better outcome. |
| Average Perceived Personal Colorectal Cancer Risk of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | 1 day (immediately before viewing intervention [baseline/T1] and after viewing intervention [post-intervention/T1]); and approximately 4-30 days after viewing intervention and 4-14 days after provider visit (post-provider visit/T2) | Multiple choice questions assessing the patients' perception of how likely they are to get colon cancer in the next 5 years, in the next 10 years, and sometime during their lifetime. Each has response options: 4=very likely, 3=somewhat likely, 2=somewhat unlikely, and 1=very unlikely. The mean of the 3 questions was calculated (each combined score has a range of 1 to 4) at each time point. We calculated the change from baseline (T0) to post-intervention (T1), post-intervention (T1) to post-provider visit (T2), and from baseline (T0) to post-provider (T2) by using the mean of the later time point minus the mean of the former time point. The range for change could be from -3 to 3 with higher values meaning an increase in perceived risk. |
| Average Decision Conflict of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | 1 day (immediately before viewing intervention [baseline/T1] and after viewing intervention [post-intervention/T1]); and approximately 4-30 days after viewing intervention and 4-14 days after provider visit (post-provider visit/T2) | Patients' decision conflict is assessed using the low literacy version of the Decision Conflict Scale, a ten-item instrument that assesses patients' subjective feeling regarding the decision process over five areas. Each item has three response categories (yes, no, unsure). Scores are summed; divided by 10; and multiplied by 25. Scores range from 0 \[no decisional conflict\] to 100 \[extremely high decisional conflict\]. Negative change means decision conflict decreased. A decrease in decision conflict is a better outcome. |
| Number of Participants Who Completed Colorectal Cancer Screening by Type of Screening Test Completed | 6 months after participant enrollment | Colorectal cancer (CRC) screening uptake and type of screening test completed within 6 months of enrolled was assessed, as documented in the electronic health record (EHR). |
| Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Decision Quality Instrument | approximately 4-30 days after viewing intervention and 4-14 days after provider visit [post-provider visit/T2] | A single-item measure taken from the Colon Cancer Testing Decision Quality Worksheet v.2.0 assessing if the patients' primary care provider asked them which type of colon cancer screening test they wanted. |
| Participant's Average Perception of Shared-Decision Making as Assessed by CollaboRATE | approximately 4-30 days after viewing intervention and 4-14 days after provider visit [post-provider visit/T2] | A 3-item measure assessing how much effort was made by their provider to: explain colon cancer screening, ask for screening preferences, and incorporate those preferences into the decision. Response options ranged from 0=No effort was made to 9=Every effort was made. The three items were summed and a mean was calculated. Scores can range from 0-9. A higher score indicates more perceived shared decision making. Higher perceived shared decision making is a better outcome. |
| Number of Participants With Orders for a Colorectal Cancer Screening (CRC) Test | 6 months after patient enrollment | A FIT, colonoscopy, or other CRC screening test ordered within 6 months of each participants' enrollment based on documentation in the electronic health record (EHR). |
| Number of Providers Who Open Their Provider Notification | 6 months after patient enrollment | Opening the provider notification sent for each patient was assessed by reviewing the electronic health record (EHR). |
| Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | approximately 4-30 days after viewing intervention and 4-14 days after provider visit [post-provider visit/T2] | Patients answered four items assessing the extent to which they were involved in the decision-making process. Each item had response options: 1= A lot; 2=Some; 3=A little; 4=Not at all. Each item was analyzed separately and responses A lot, Some and A little were considered enough and received 1 point. The response Not at all was considered not enough and received 0 points. |
| Average Intention to Get a Colorectal Cancer (CRC) Screening Test of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | 1 day (immediately before viewing intervention [baseline/T1] and after viewing intervention [post-intervention/T1]); and approximately 4-30 days after viewing intervention and 4-14 days after provider visit (post-provider visit/T2) | Patients' intention to be screened for CRC with any CRC screening test will be measured with 1 item: Do you plan to get any type of colon cancer screening test within the next 6 months?. The response options were: 5=Definitely; 4=Probably; 3=May or may not; 2=Probably not; and 1=Definitely not. Higher positive change means CRC screening intention increased. Increased intention to be screened is a better outcome. |
Countries
United States
Participant flow
Recruitment details
Patients were recruited from primary care practices between January 2021 and November 2022.
Participants by arm
| Arm | Count |
|---|---|
| Group 1 Patients view decision aid without personalized message and whose providers do not receive the personalized message.
Decision aid without personalized message: The decision aid without personalized message consists of a PowerPoint presentation converted to mp4 (video) with text, photos, and an audio track, that is advanced by the viewer and can be viewed online. It begins with a 60 sec video on CRC screening produced by the Centers for Disease Control and Prevention (CDC), followed by slides summarizing the advantages and disadvantages of colonoscopy and stool testing with the fecal immunochemical test (FIT) and DNA+FIT (Cologuard). The presentation is approximately 10 minutes long.
Provider notification without personalized message: Providers will receive a message informing them that their enrolled patient is due for CRC screening. The notification will be sent to them through the EHR within 24 hours of their visit with the enrolled patient. | 290 |
| Group 2 Patients view decision aid with personalized message and whose providers do not receive the personalized message.
Decision aid with personalized message: The decision aid with personalized message will first present the decision aid without personalized message followed by additional PowerPoint slides converted to mp4 (video) with text, photos, and an audio track briefly explaining the risk tool, the participant's score on the 5 risk factors, total score, ACN risk, and implications for screening and test choice. The presentation is approximately 14 minutes long.
Provider notification without personalized message: Providers will receive a message informing them that their enrolled patient is due for CRC screening. The notification will be sent to them through the EHR within 24 hours of their visit with the enrolled patient. | 262 |
| Group 3 Patient view decision aid without the personalized message and whose providers receive the personalized message.
Decision aid without personalized message: The decision aid without personalized message consists of a PowerPoint presentation converted to mp4 (video) with text, photos, and an audio track, that is advanced by the viewer and can be viewed online. It begins with a 60 sec video on CRC screening produced by the Centers for Disease Control and Prevention (CDC), followed by slides summarizing the advantages and disadvantages of colonoscopy and stool testing with the fecal immunochemical test (FIT) and DNA+FIT (Cologuard). The presentation is approximately 10 minutes long.
Provider notification with personalized message: Providers will receive a message informing them that their enrolled patient is due for CRC screening. The notification will also include the patient's ACN risk (very low, low, moderate, high-average) and implications for screening decisions and test choice. Links to a web landing page containing a more detailed explanation of the risk tool and additional references will be included. The notification will be sent to them through the EHR within 24 hours of their visit with the enrolled patient. | 247 |
| Group 4 Patients view decision aid with the personalized message and whose providers receive the personalized message.
Decision aid with personalized message: The decision aid with personalized message will first present the decision aid without personalized message followed by additional PowerPoint slides converted to mp4 (video) with text, photos, and an audio track briefly explaining the risk tool, the participant's score on the 5 risk factors, total score, ACN risk, and implications for screening and test choice. The presentation is approximately 14 minutes long.
Provider notification with personalized message: Providers will receive a message informing them that their enrolled patient is due for CRC screening. The notification will also include the patient's ACN risk (very low, low, moderate, high-average) and implications for screening decisions and test choice. Links to a web landing page containing a more detailed explanation of the risk tool and additional references will be included. The notification will be sent to them through the EHR within 24 hours of their visit with the enrolled patient. | 285 |
| Total | 1,084 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 | FG002 | FG003 |
|---|---|---|---|---|---|
| Overall Study | Determined patient was not eligible | 3 | 3 | 12 | 3 |
| Overall Study | Withdrawal by Subject | 1 | 0 | 3 | 2 |
Baseline characteristics
| Characteristic | Group 1 | Group 2 | Group 3 | Group 4 | Total |
|---|---|---|---|---|---|
| Age, Continuous | 56.2 years STANDARD_DEVIATION 5.9 | 56.8 years STANDARD_DEVIATION 6.5 | 56.5 years STANDARD_DEVIATION 6.2 | 56.4 years STANDARD_DEVIATION 6.2 | 56.5 years STANDARD_DEVIATION 6.2 |
| Education - highest level Associates degree | 28 Participants | 32 Participants | 24 Participants | 26 Participants | 110 Participants |
| Education - highest level Bachelors degree | 69 Participants | 42 Participants | 53 Participants | 68 Participants | 232 Participants |
| Education - highest level High school graduate/GED | 45 Participants | 54 Participants | 55 Participants | 55 Participants | 209 Participants |
| Education - highest level Less than high school | 9 Participants | 16 Participants | 10 Participants | 10 Participants | 45 Participants |
| Education - highest level Prefer not to answer | 9 Participants | 6 Participants | 6 Participants | 5 Participants | 26 Participants |
| Education - highest level Professional or graduate degree | 38 Participants | 33 Participants | 29 Participants | 45 Participants | 145 Participants |
| Education - highest level Some college or technical school/trade school | 79 Participants | 67 Participants | 59 Participants | 68 Participants | 273 Participants |
| Education - highest level Unknown or Not Reported | 13 Participants | 12 Participants | 11 Participants | 8 Participants | 44 Participants |
| Employed? No | 95 Participants | 85 Participants | 89 Participants | 105 Participants | 374 Participants |
| Employed? Unknown or Not Reported | 12 Participants | 12 Participants | 11 Participants | 8 Participants | 43 Participants |
| Employed? Yes | 183 Participants | 165 Participants | 147 Participants | 172 Participants | 667 Participants |
| Health Insurance? No | 10 Participants | 9 Participants | 9 Participants | 13 Participants | 41 Participants |
| Health Insurance? Unknown or Not Reported | 12 Participants | 12 Participants | 10 Participants | 8 Participants | 42 Participants |
| Health Insurance? Yes | 268 Participants | 241 Participants | 228 Participants | 264 Participants | 1001 Participants |
| Health Literacy | 2.1 units on a scale STANDARD_DEVIATION 2.4 | 1.9 units on a scale STANDARD_DEVIATION 2.2 | 2.1 units on a scale STANDARD_DEVIATION 2.2 | 1.9 units on a scale STANDARD_DEVIATION 2.2 | 2.0 units on a scale STANDARD_DEVIATION 2.3 |
| Insurance Lapse over 12 Months? No | 238 Participants | 227 Participants | 200 Participants | 239 Participants | 904 Participants |
| Insurance Lapse over 12 Months? Unknown or Not Reported | 25 Participants | 23 Participants | 23 Participants | 22 Participants | 93 Participants |
| Insurance Lapse over 12 Months? Yes | 27 Participants | 12 Participants | 24 Participants | 24 Participants | 87 Participants |
| Perceived Comparative Risk for Colorectal Cancer About the same as other women/men your age | 111 Participants | 101 Participants | 101 Participants | 110 Participants | 423 Participants |
| Perceived Comparative Risk for Colorectal Cancer Don't know | 88 Participants | 92 Participants | 72 Participants | 86 Participants | 338 Participants |
| Perceived Comparative Risk for Colorectal Cancer Higher than other women/men your age | 13 Participants | 7 Participants | 15 Participants | 9 Participants | 44 Participants |
| Perceived Comparative Risk for Colorectal Cancer Lower than other women/men your age | 68 Participants | 54 Participants | 53 Participants | 73 Participants | 248 Participants |
| Perceived Comparative Risk for Colorectal Cancer Unknown or Not Reported | 10 Participants | 8 Participants | 6 Participants | 7 Participants | 31 Participants |
| Race/Ethnicity, Customized Consolidated Race Black | 76 Participants | 63 Participants | 74 Participants | 77 Participants | 290 Participants |
| Race/Ethnicity, Customized Consolidated Race Hispanic | 13 Participants | 7 Participants | 8 Participants | 6 Participants | 34 Participants |
| Race/Ethnicity, Customized Consolidated Race Other | 17 Participants | 15 Participants | 8 Participants | 13 Participants | 53 Participants |
| Race/Ethnicity, Customized Consolidated Race Unknown or Not Reported | 13 Participants | 12 Participants | 9 Participants | 9 Participants | 43 Participants |
| Race/Ethnicity, Customized Consolidated Race White | 171 Participants | 165 Participants | 148 Participants | 180 Participants | 664 Participants |
| Region of Enrollment United States | 290 participants | 262 participants | 247 participants | 285 participants | 1084 participants |
| Relationship Divorced | 69 Participants | 46 Participants | 54 Participants | 62 Participants | 231 Participants |
| Relationship Married or living with a partner | 140 Participants | 141 Participants | 128 Participants | 144 Participants | 553 Participants |
| Relationship Never married | 43 Participants | 43 Participants | 40 Participants | 43 Participants | 169 Participants |
| Relationship Separated | 14 Participants | 7 Participants | 9 Participants | 10 Participants | 40 Participants |
| Relationship Unknown or Not Reported | 12 Participants | 12 Participants | 9 Participants | 9 Participants | 42 Participants |
| Relationship Widowed | 12 Participants | 13 Participants | 7 Participants | 17 Participants | 49 Participants |
| Self-reported Health Status at Baseline Excellent | 10 Participants | 10 Participants | 10 Participants | 16 Participants | 46 Participants |
| Self-reported Health Status at Baseline Fair | 74 Participants | 62 Participants | 58 Participants | 64 Participants | 258 Participants |
| Self-reported Health Status at Baseline Good | 121 Participants | 117 Participants | 104 Participants | 114 Participants | 456 Participants |
| Self-reported Health Status at Baseline Missing or Not Reported | 14 Participants | 12 Participants | 10 Participants | 8 Participants | 44 Participants |
| Self-reported Health Status at Baseline Poor | 12 Participants | 9 Participants | 15 Participants | 13 Participants | 49 Participants |
| Self-reported Health Status at Baseline Very Good | 59 Participants | 52 Participants | 50 Participants | 70 Participants | 231 Participants |
| Sex: Female, Male Female | 173 Participants | 155 Participants | 140 Participants | 179 Participants | 647 Participants |
| Sex: Female, Male Male | 117 Participants | 107 Participants | 107 Participants | 106 Participants | 437 Participants |
| Subjective Income Level Are comfortable | 124 Participants | 134 Participants | 114 Participants | 126 Participants | 498 Participants |
| Subjective Income Level Do NOT have enough to make ends meet | 41 Participants | 23 Participants | 36 Participants | 42 Participants | 142 Participants |
| Subjective Income Level Have just enough to make ends meet | 109 Participants | 93 Participants | 86 Participants | 108 Participants | 396 Participants |
| Subjective Income Level Missing or Not Reported | 16 Participants | 12 Participants | 11 Participants | 9 Participants | 48 Participants |
| Subjective Numeracy | 4.2 units on a scale STANDARD_DEVIATION 1.3 | 4.3 units on a scale STANDARD_DEVIATION 1.2 | 4.2 units on a scale STANDARD_DEVIATION 1.3 | 4.3 units on a scale STANDARD_DEVIATION 1.2 | 4.3 units on a scale STANDARD_DEVIATION 1.3 |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk | EG003 affected / at risk |
|---|---|---|---|---|
| deaths Total, all-cause mortality | 0 / 290 | 0 / 262 | 0 / 247 | 0 / 285 |
| other Total, other adverse events | 0 / 290 | 0 / 262 | 0 / 247 | 0 / 285 |
| serious Total, serious adverse events | 0 / 290 | 0 / 262 | 0 / 247 | 0 / 285 |
Outcome results
Primary
Number of Participants Who Completed Colorectal Cancer Screening
Patients' completion of colonoscopy, fecal immunochemical testing (FIT), or other CRC screening within 6 months, based on documentation in the participants' electronic health record.
Time frame: 6 months after patient enrollment
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Group 1 | Number of Participants Who Completed Colorectal Cancer Screening | 110 Participants |
| Group 2 | Number of Participants Who Completed Colorectal Cancer Screening | 95 Participants |
| Group 3 | Number of Participants Who Completed Colorectal Cancer Screening | 113 Participants |
| Group 4 | Number of Participants Who Completed Colorectal Cancer Screening | 113 Participants |
Primary
Number of Participants Who Made a High Quality Decision Using the Multi-dimensional Measure of Informed Consent (MMIC) Which Incorporates Knowledge, Intent, and Behavior.
Decision quality will be assessed using the multi-dimensional measure of informed consent (MMIC), where a high-quality decision is one where the individual has adequate knowledge regarding the available options and undergoes the screening test that he or she has chosen or that fits his or her values (values concordance). Patient knowledge of colorectal cancer and screening will be assessed by a 12-item test made up of 6 multiple choice questions and 6 true-false questions. Adequate knowledge = 9 correct. Concordance will be measured between the patient's test choice at the post-provider survey and the screening test underwent, if any, within 6 months after patient enrollment.
Time frame: 6 months after participant enrollment
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Group 1 | Number of Participants Who Made a High Quality Decision Using the Multi-dimensional Measure of Informed Consent (MMIC) Which Incorporates Knowledge, Intent, and Behavior. | 90 Participants |
| Group 2 | Number of Participants Who Made a High Quality Decision Using the Multi-dimensional Measure of Informed Consent (MMIC) Which Incorporates Knowledge, Intent, and Behavior. | 92 Participants |
| Group 3 | Number of Participants Who Made a High Quality Decision Using the Multi-dimensional Measure of Informed Consent (MMIC) Which Incorporates Knowledge, Intent, and Behavior. | 91 Participants |
| Group 4 | Number of Participants Who Made a High Quality Decision Using the Multi-dimensional Measure of Informed Consent (MMIC) Which Incorporates Knowledge, Intent, and Behavior. | 103 Participants |
Secondary
Average Correct Responses of Participants to Knowledge Questions About Colorectal Cancer (CRC) and CRC Screening: Change Between Baseline, Post-intervention, and Post-provider Visit.
Knowledge was assessed with six multiple choice and six true/false questions regarding general information (including risk factors, screening test options, and test frequency) of CRC and CRC screening. Knowledge scores were derived by summing correct responses to the 12 individual knowledge questions (range, 0-12), and change was calculated from baseline (T0) to post-intervention (T1), post-intervention (T1) to post-provider visit (T2), and from baseline (T0) to post-provider (T2) by using the knowledge score at the later time point minus the knowledge score of the former time point. The range for change could be -12 to 12 with higher values meaning an increase in knowledge which is a better outcome.
Time frame: 1 day (immediately before viewing intervention [baseline/T1] and after viewing intervention [post-intervention/T1]); and approximately 4-30 days after viewing intervention and 4-14 days after provider visit (post-provider visit/T2)
Population: Only participants who completed the item at each time point under comparison were used in the analysis.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Group 1 | Average Correct Responses of Participants to Knowledge Questions About Colorectal Cancer (CRC) and CRC Screening: Change Between Baseline, Post-intervention, and Post-provider Visit. | Change in correct responses from baseline (T0) to post-intervention (T1) | 3.65 units on a scale-number correct | Standard Deviation 2.68 |
| Group 1 | Average Correct Responses of Participants to Knowledge Questions About Colorectal Cancer (CRC) and CRC Screening: Change Between Baseline, Post-intervention, and Post-provider Visit. | Change in correct responses from baseline (T0) to post-provider visit (T2) | 3.03 units on a scale-number correct | Standard Deviation 2.71 |
| Group 1 | Average Correct Responses of Participants to Knowledge Questions About Colorectal Cancer (CRC) and CRC Screening: Change Between Baseline, Post-intervention, and Post-provider Visit. | Change in correct responses from post-intervention (T1) to post-provider visit (T2) | -0.60 units on a scale-number correct | Standard Deviation 1.4 |
| Group 2 | Average Correct Responses of Participants to Knowledge Questions About Colorectal Cancer (CRC) and CRC Screening: Change Between Baseline, Post-intervention, and Post-provider Visit. | Change in correct responses from baseline (T0) to post-intervention (T1) | 3.70 units on a scale-number correct | Standard Deviation 2.74 |
| Group 2 | Average Correct Responses of Participants to Knowledge Questions About Colorectal Cancer (CRC) and CRC Screening: Change Between Baseline, Post-intervention, and Post-provider Visit. | Change in correct responses from baseline (T0) to post-provider visit (T2) | 3.10 units on a scale-number correct | Standard Deviation 2.79 |
| Group 2 | Average Correct Responses of Participants to Knowledge Questions About Colorectal Cancer (CRC) and CRC Screening: Change Between Baseline, Post-intervention, and Post-provider Visit. | Change in correct responses from post-intervention (T1) to post-provider visit (T2) | -0.58 units on a scale-number correct | Standard Deviation 1.31 |
| Group 3 | Average Correct Responses of Participants to Knowledge Questions About Colorectal Cancer (CRC) and CRC Screening: Change Between Baseline, Post-intervention, and Post-provider Visit. | Change in correct responses from post-intervention (T1) to post-provider visit (T2) | -0.60 units on a scale-number correct | Standard Deviation 1.6 |
| Group 3 | Average Correct Responses of Participants to Knowledge Questions About Colorectal Cancer (CRC) and CRC Screening: Change Between Baseline, Post-intervention, and Post-provider Visit. | Change in correct responses from baseline (T0) to post-intervention (T1) | 3.75 units on a scale-number correct | Standard Deviation 2.82 |
| Group 3 | Average Correct Responses of Participants to Knowledge Questions About Colorectal Cancer (CRC) and CRC Screening: Change Between Baseline, Post-intervention, and Post-provider Visit. | Change in correct responses from baseline (T0) to post-provider visit (T2) | 3.02 units on a scale-number correct | Standard Deviation 3.02 |
| Group 4 | Average Correct Responses of Participants to Knowledge Questions About Colorectal Cancer (CRC) and CRC Screening: Change Between Baseline, Post-intervention, and Post-provider Visit. | Change in correct responses from baseline (T0) to post-intervention (T1) | 3.76 units on a scale-number correct | Standard Deviation 2.9 |
| Group 4 | Average Correct Responses of Participants to Knowledge Questions About Colorectal Cancer (CRC) and CRC Screening: Change Between Baseline, Post-intervention, and Post-provider Visit. | Change in correct responses from baseline (T0) to post-provider visit (T2) | 3.31 units on a scale-number correct | Standard Deviation 2.83 |
| Group 4 | Average Correct Responses of Participants to Knowledge Questions About Colorectal Cancer (CRC) and CRC Screening: Change Between Baseline, Post-intervention, and Post-provider Visit. | Change in correct responses from post-intervention (T1) to post-provider visit (T2) | -0.43 units on a scale-number correct | Standard Deviation 1.45 |
Secondary
Average Decision Conflict of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit
Patients' decision conflict is assessed using the low literacy version of the Decision Conflict Scale, a ten-item instrument that assesses patients' subjective feeling regarding the decision process over five areas. Each item has three response categories (yes, no, unsure). Scores are summed; divided by 10; and multiplied by 25. Scores range from 0 \[no decisional conflict\] to 100 \[extremely high decisional conflict\]. Negative change means decision conflict decreased. A decrease in decision conflict is a better outcome.
Time frame: 1 day (immediately before viewing intervention [baseline/T1] and after viewing intervention [post-intervention/T1]); and approximately 4-30 days after viewing intervention and 4-14 days after provider visit (post-provider visit/T2)
Population: Only participants who completed the item at each time point under comparison were used in the analysis.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Group 1 | Average Decision Conflict of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-intervention (T1) | -36.6 score on a scale | Standard Deviation 28.9 |
| Group 1 | Average Decision Conflict of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-provider visit (T2) | -39.0 score on a scale | Standard Deviation 29.2 |
| Group 1 | Average Decision Conflict of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from post-intervention (T1) to post-provider visit (T2) | -1.60 score on a scale | Standard Deviation 12.1 |
| Group 2 | Average Decision Conflict of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-intervention (T1) | -42.4 score on a scale | Standard Deviation 27.6 |
| Group 2 | Average Decision Conflict of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-provider visit (T2) | -41.6 score on a scale | Standard Deviation 28.8 |
| Group 2 | Average Decision Conflict of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from post-intervention (T1) to post-provider visit (T2) | -0.76 score on a scale | Standard Deviation 9.53 |
| Group 3 | Average Decision Conflict of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from post-intervention (T1) to post-provider visit (T2) | -2.32 score on a scale | Standard Deviation 11.6 |
| Group 3 | Average Decision Conflict of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-intervention (T1) | -37.1 score on a scale | Standard Deviation 27.7 |
| Group 3 | Average Decision Conflict of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-provider visit (T2) | -37.9 score on a scale | Standard Deviation 29.2 |
| Group 4 | Average Decision Conflict of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-intervention (T1) | -40.3 score on a scale | Standard Deviation 28.4 |
| Group 4 | Average Decision Conflict of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-provider visit (T2) | -39.3 score on a scale | Standard Deviation 29.2 |
| Group 4 | Average Decision Conflict of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from post-intervention (T1) to post-provider visit (T2) | -0.27 score on a scale | Standard Deviation 11.6 |
Secondary
Average Intention to Get a Colorectal Cancer (CRC) Screening Test of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit
Patients' intention to be screened for CRC with any CRC screening test will be measured with 1 item: Do you plan to get any type of colon cancer screening test within the next 6 months?. The response options were: 5=Definitely; 4=Probably; 3=May or may not; 2=Probably not; and 1=Definitely not. Higher positive change means CRC screening intention increased. Increased intention to be screened is a better outcome.
Time frame: 1 day (immediately before viewing intervention [baseline/T1] and after viewing intervention [post-intervention/T1]); and approximately 4-30 days after viewing intervention and 4-14 days after provider visit (post-provider visit/T2)
Population: Only participants who completed the item at each time point under comparison were used in the analysis.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Group 1 | Average Intention to Get a Colorectal Cancer (CRC) Screening Test of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-intervention (T1) | 0.59 score on a scale | Standard Deviation 0.79 |
| Group 1 | Average Intention to Get a Colorectal Cancer (CRC) Screening Test of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-provider visit (T2) | 0.85 score on a scale | Standard Deviation 1.18 |
| Group 1 | Average Intention to Get a Colorectal Cancer (CRC) Screening Test of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from post-intervention (T1) to post-provider visit (T2) | 0.23 score on a scale | Standard Deviation 0.93 |
| Group 2 | Average Intention to Get a Colorectal Cancer (CRC) Screening Test of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-intervention (T1) | 0.68 score on a scale | Standard Deviation 0.86 |
| Group 2 | Average Intention to Get a Colorectal Cancer (CRC) Screening Test of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-provider visit (T2) | 0.94 score on a scale | Standard Deviation 1.01 |
| Group 2 | Average Intention to Get a Colorectal Cancer (CRC) Screening Test of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from post-intervention (T1) to post-provider visit (T2) | 0.24 score on a scale | Standard Deviation 0.74 |
| Group 3 | Average Intention to Get a Colorectal Cancer (CRC) Screening Test of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from post-intervention (T1) to post-provider visit (T2) | 0.24 score on a scale | Standard Deviation 0.82 |
| Group 3 | Average Intention to Get a Colorectal Cancer (CRC) Screening Test of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-intervention (T1) | 0.55 score on a scale | Standard Deviation 0.84 |
| Group 3 | Average Intention to Get a Colorectal Cancer (CRC) Screening Test of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-provider visit (T2) | 0.80 score on a scale | Standard Deviation 1.15 |
| Group 4 | Average Intention to Get a Colorectal Cancer (CRC) Screening Test of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-intervention (T1) | 0.63 score on a scale | Standard Deviation 0.83 |
| Group 4 | Average Intention to Get a Colorectal Cancer (CRC) Screening Test of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-provider visit (T2) | 0.82 score on a scale | Standard Deviation 1.05 |
| Group 4 | Average Intention to Get a Colorectal Cancer (CRC) Screening Test of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from post-intervention (T1) to post-provider visit (T2) | 0.20 score on a scale | Standard Deviation 0.79 |
Secondary
Average Perceived Personal Colorectal Cancer Risk of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit
Multiple choice questions assessing the patients' perception of how likely they are to get colon cancer in the next 5 years, in the next 10 years, and sometime during their lifetime. Each has response options: 4=very likely, 3=somewhat likely, 2=somewhat unlikely, and 1=very unlikely. The mean of the 3 questions was calculated (each combined score has a range of 1 to 4) at each time point. We calculated the change from baseline (T0) to post-intervention (T1), post-intervention (T1) to post-provider visit (T2), and from baseline (T0) to post-provider (T2) by using the mean of the later time point minus the mean of the former time point. The range for change could be from -3 to 3 with higher values meaning an increase in perceived risk.
Time frame: 1 day (immediately before viewing intervention [baseline/T1] and after viewing intervention [post-intervention/T1]); and approximately 4-30 days after viewing intervention and 4-14 days after provider visit (post-provider visit/T2)
Population: Only participants who completed the item at each time point under comparison were used in the analysis.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Group 1 | Average Perceived Personal Colorectal Cancer Risk of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-provider visit (T2) | 0.14 score on a scale | Standard Deviation 0.79 |
| Group 1 | Average Perceived Personal Colorectal Cancer Risk of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from post-intervention (T1) to post-provider visit (T2) | -0.10 score on a scale | Standard Deviation 0.86 |
| Group 1 | Average Perceived Personal Colorectal Cancer Risk of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-intervention (T1) | 0.21 score on a scale | Standard Deviation 0.74 |
| Group 2 | Average Perceived Personal Colorectal Cancer Risk of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-provider visit (T2) | 0.28 score on a scale | Standard Deviation 0.87 |
| Group 2 | Average Perceived Personal Colorectal Cancer Risk of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-intervention (T1) | 0.15 score on a scale | Standard Deviation 0.78 |
| Group 2 | Average Perceived Personal Colorectal Cancer Risk of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from post-intervention (T1) to post-provider visit (T2) | 0.12 score on a scale | Standard Deviation 0.82 |
| Group 3 | Average Perceived Personal Colorectal Cancer Risk of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-intervention (T1) | 0.14 score on a scale | Standard Deviation 0.81 |
| Group 3 | Average Perceived Personal Colorectal Cancer Risk of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from post-intervention (T1) to post-provider visit (T2) | 0.10 score on a scale | Standard Deviation 0.87 |
| Group 3 | Average Perceived Personal Colorectal Cancer Risk of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-provider visit (T2) | 0.21 score on a scale | Standard Deviation 0.98 |
| Group 4 | Average Perceived Personal Colorectal Cancer Risk of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-provider visit (T2) | 0.14 score on a scale | Standard Deviation 0.84 |
| Group 4 | Average Perceived Personal Colorectal Cancer Risk of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from post-intervention (T1) to post-provider visit (T2) | 0.05 score on a scale | Standard Deviation 0.83 |
| Group 4 | Average Perceived Personal Colorectal Cancer Risk of Participants: Change Between Baseline, Post-intervention, and Post-provider Visit | Change from baseline (T0) to post-intervention (T1) | 0.08 score on a scale | Standard Deviation 0.77 |
Secondary
Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior
For those patients who answer the screening intent item with definitely not, probably not, or may or may not, test choice will be categorized as no screening. Those who answer Screening Intent with Probably or Definitely have Test Choice categorized based on their answer to a single item: If you have a colon test, which one would you choose? Response options are: Stool test (FIT or Cologuard), Colonoscopy, Another test, or Don't know.
Time frame: 1 day (immediately before viewing intervention [baseline/T1] and after viewing intervention [post-intervention/T1]); and approximately 4-30 days after viewing intervention and 4-14 days after provider visit (post-provider visit/T2)
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Group 1 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Unknown or not reported | 61 Participants |
| Group 1 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Intends to be screened and don't know which test | 25 Participants |
| Group 1 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Intends to be screened with another test | 2 Participants |
| Group 1 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Intends to be screened with a stool test (FIT or Cologuard) | 92 Participants |
| Group 1 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Does not intend to be screened | 52 Participants |
| Group 1 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Unknown or not reported | 22 Participants |
| Group 1 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Intends to be screened with colonoscopy | 70 Participants |
| Group 1 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Intends to be screened with colonoscopy | 104 Participants |
| Group 1 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Intends to be screened and don't know which test | 37 Participants |
| Group 1 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Does not intend to be screened | 26 Participants |
| Group 1 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Does not intend to be screened | 111 Participants |
| Group 1 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Intends to be screened with a stool test (FIT or Cologuard) | 62 Participants |
| Group 1 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Unknown or not reported | 8 Participants |
| Group 1 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Intends to be screened and don't know which test | 6 Participants |
| Group 1 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Intends to be screened with colonoscopy | 106 Participants |
| Group 1 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Intends to be screened with a stool test (FIT or Cologuard) | 85 Participants |
| Group 1 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Intends to be screened with another test | 1 Participants |
| Group 1 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Intends to be screened with another test | 0 Participants |
| Group 2 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Intends to be screened with colonoscopy | 82 Participants |
| Group 2 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Intends to be screened with a stool test (FIT or Cologuard) | 84 Participants |
| Group 2 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Intends to be screened with a stool test (FIT or Cologuard) | 53 Participants |
| Group 2 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Intends to be screened and don't know which test | 18 Participants |
| Group 2 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Does not intend to be screened | 105 Participants |
| Group 2 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Intends to be screened with another test | 1 Participants |
| Group 2 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Intends to be screened and don't know which test | 5 Participants |
| Group 2 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Does not intend to be screened | 40 Participants |
| Group 2 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Intends to be screened with another test | 3 Participants |
| Group 2 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Intends to be screened with colonoscopy | 90 Participants |
| Group 2 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Intends to be screened with another test | 0 Participants |
| Group 2 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Unknown or not reported | 16 Participants |
| Group 2 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Unknown or not reported | 6 Participants |
| Group 2 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Intends to be screened with a stool test (FIT or Cologuard) | 106 Participants |
| Group 2 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Does not intend to be screened | 25 Participants |
| Group 2 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Intends to be screened with colonoscopy | 58 Participants |
| Group 2 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Intends to be screened and don't know which test | 37 Participants |
| Group 2 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Unknown or not reported | 57 Participants |
| Group 3 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Intends to be screened and don't know which test | 2 Participants |
| Group 3 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Intends to be screened with another test | 0 Participants |
| Group 3 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Unknown or not reported | 4 Participants |
| Group 3 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Intends to be screened with colonoscopy | 56 Participants |
| Group 3 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Intends to be screened with a stool test (FIT or Cologuard) | 55 Participants |
| Group 3 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Intends to be screened with another test | 2 Participants |
| Group 3 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Intends to be screened and don't know which test | 35 Participants |
| Group 3 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Does not intend to be screened | 95 Participants |
| Group 3 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Intends to be screened with colonoscopy | 93 Participants |
| Group 3 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Intends to be screened with a stool test (FIT or Cologuard) | 74 Participants |
| Group 3 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Intends to be screened with another test | 1 Participants |
| Group 3 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Intends to be screened and don't know which test | 19 Participants |
| Group 3 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Does not intend to be screened | 39 Participants |
| Group 3 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Unknown or not reported | 21 Participants |
| Group 3 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Intends to be screened with colonoscopy | 83 Participants |
| Group 3 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Intends to be screened with a stool test (FIT or Cologuard) | 89 Participants |
| Group 3 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Does not intend to be screened | 25 Participants |
| Group 3 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Unknown or not reported | 48 Participants |
| Group 4 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Intends to be screened with another test | 0 Participants |
| Group 4 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Intends to be screened with colonoscopy | 79 Participants |
| Group 4 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Intends to be screened with a stool test (FIT or Cologuard) | 117 Participants |
| Group 4 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Intends to be screened with a stool test (FIT or Cologuard) | 133 Participants |
| Group 4 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Intends to be screened with colonoscopy | 86 Participants |
| Group 4 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Intends to be screened with another test | 1 Participants |
| Group 4 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Unknown or not reported | 3 Participants |
| Group 4 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Does not intend to be screened | 99 Participants |
| Group 4 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Intends to be screened with colonoscopy | 89 Participants |
| Group 4 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Intends to be screened and don't know which test | 3 Participants |
| Group 4 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Intends to be screened and don't know which test | 32 Participants |
| Group 4 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Intends to be screened with another test | 2 Participants |
| Group 4 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Unknown or not reported | 48 Participants |
| Group 4 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-provider (T2) | Does not intend to be screened | 27 Participants |
| Group 4 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Unknown or not reported | 16 Participants |
| Group 4 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Does not intend to be screened | 31 Participants |
| Group 4 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at baseline (T0) | Intends to be screened with a stool test (FIT or Cologuard) | 70 Participants |
| Group 4 | Number of Participants Intended Colorectal Cancer (CRC) Screening Behavior | Intended screening behavior at post-intervention (T1) | Intends to be screened and don't know which test | 19 Participants |
Secondary
Number of Participants Who Completed Colorectal Cancer Screening by Type of Screening Test Completed
Colorectal cancer (CRC) screening uptake and type of screening test completed within 6 months of enrolled was assessed, as documented in the electronic health record (EHR).
Time frame: 6 months after participant enrollment
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Group 1 | Number of Participants Who Completed Colorectal Cancer Screening by Type of Screening Test Completed | Completed a colonoscopy | 59 Participants |
| Group 1 | Number of Participants Who Completed Colorectal Cancer Screening by Type of Screening Test Completed | Did not complete a CRC screening test | 180 Participants |
| Group 1 | Number of Participants Who Completed Colorectal Cancer Screening by Type of Screening Test Completed | Completed a stool test (FIT or Cologuard) | 51 Participants |
| Group 2 | Number of Participants Who Completed Colorectal Cancer Screening by Type of Screening Test Completed | Completed a colonoscopy | 39 Participants |
| Group 2 | Number of Participants Who Completed Colorectal Cancer Screening by Type of Screening Test Completed | Did not complete a CRC screening test | 167 Participants |
| Group 2 | Number of Participants Who Completed Colorectal Cancer Screening by Type of Screening Test Completed | Completed a stool test (FIT or Cologuard) | 56 Participants |
| Group 3 | Number of Participants Who Completed Colorectal Cancer Screening by Type of Screening Test Completed | Completed a stool test (FIT or Cologuard) | 61 Participants |
| Group 3 | Number of Participants Who Completed Colorectal Cancer Screening by Type of Screening Test Completed | Completed a colonoscopy | 52 Participants |
| Group 3 | Number of Participants Who Completed Colorectal Cancer Screening by Type of Screening Test Completed | Did not complete a CRC screening test | 134 Participants |
| Group 4 | Number of Participants Who Completed Colorectal Cancer Screening by Type of Screening Test Completed | Completed a colonoscopy | 51 Participants |
| Group 4 | Number of Participants Who Completed Colorectal Cancer Screening by Type of Screening Test Completed | Did not complete a CRC screening test | 172 Participants |
| Group 4 | Number of Participants Who Completed Colorectal Cancer Screening by Type of Screening Test Completed | Completed a stool test (FIT or Cologuard) | 62 Participants |
Secondary
Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Decision Quality Instrument
A single-item measure taken from the Colon Cancer Testing Decision Quality Worksheet v.2.0 assessing if the patients' primary care provider asked them which type of colon cancer screening test they wanted.
Time frame: approximately 4-30 days after viewing intervention and 4-14 days after provider visit [post-provider visit/T2]
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Group 1 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Decision Quality Instrument | Yes | 152 Participants |
| Group 1 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Decision Quality Instrument | Unknown or not reported | 62 Participants |
| Group 1 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Decision Quality Instrument | No | 76 Participants |
| Group 2 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Decision Quality Instrument | Yes | 134 Participants |
| Group 2 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Decision Quality Instrument | Unknown or not reported | 56 Participants |
| Group 2 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Decision Quality Instrument | No | 72 Participants |
| Group 3 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Decision Quality Instrument | No | 69 Participants |
| Group 3 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Decision Quality Instrument | Yes | 130 Participants |
| Group 3 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Decision Quality Instrument | Unknown or not reported | 48 Participants |
| Group 4 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Decision Quality Instrument | Yes | 159 Participants |
| Group 4 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Decision Quality Instrument | Unknown or not reported | 49 Participants |
| Group 4 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Decision Quality Instrument | No | 77 Participants |
Secondary
Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4
Patients answered four items assessing the extent to which they were involved in the decision-making process. Each item had response options: 1= A lot; 2=Some; 3=A little; 4=Not at all. Each item was analyzed separately and responses A lot, Some and A little were considered enough and received 1 point. The response Not at all was considered not enough and received 0 points.
Time frame: approximately 4-30 days after viewing intervention and 4-14 days after provider visit [post-provider visit/T2]
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Group 1 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to do a stool test? | Enough | 108 Participants |
| Group 1 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to do a stool test? | Unknown or not reported | 61 Participants |
| Group 1 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to do a stool test? | Not enough | 69 Participants |
| Group 1 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to have a colonoscopy? | Enough | 203 Participants |
| Group 1 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to do a stool test? | Unknown or not reported | 61 Participants |
| Group 1 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to have a colonoscopy? | Unknown or not reported | 61 Participants |
| Group 1 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to have a colonoscopy? | Enough | 106 Participants |
| Group 1 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to have a colonoscopy? | Not enough | 26 Participants |
| Group 1 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to do a stool test? | Not enough | 121 Participants |
| Group 1 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to have a colonoscopy? | Not enough | 123 Participants |
| Group 1 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to have a colonoscopy? | Unknown or not reported | 61 Participants |
| Group 1 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to do a stool test? | Enough | 160 Participants |
| Group 2 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to have a colonoscopy? | Not enough | 28 Participants |
| Group 2 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to do a stool test? | Enough | 146 Participants |
| Group 2 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to have a colonoscopy? | Enough | 89 Participants |
| Group 2 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to do a stool test? | Unknown or not reported | 56 Participants |
| Group 2 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to do a stool test? | Enough | 92 Participants |
| Group 2 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to do a stool test? | Not enough | 60 Participants |
| Group 2 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to have a colonoscopy? | Enough | 178 Participants |
| Group 2 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to have a colonoscopy? | Unknown or not reported | 56 Participants |
| Group 2 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to have a colonoscopy? | Not enough | 117 Participants |
| Group 2 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to have a colonoscopy? | Unknown or not reported | 56 Participants |
| Group 2 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to do a stool test? | Unknown or not reported | 56 Participants |
| Group 2 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to do a stool test? | Not enough | 114 Participants |
| Group 3 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to do a stool test? | Not enough | 52 Participants |
| Group 3 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to have a colonoscopy? | Enough | 164 Participants |
| Group 3 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to have a colonoscopy? | Not enough | 35 Participants |
| Group 3 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to have a colonoscopy? | Unknown or not reported | 48 Participants |
| Group 3 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to have a colonoscopy? | Enough | 91 Participants |
| Group 3 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to have a colonoscopy? | Not enough | 108 Participants |
| Group 3 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to have a colonoscopy? | Unknown or not reported | 48 Participants |
| Group 3 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to do a stool test? | Enough | 146 Participants |
| Group 3 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to do a stool test? | Unknown or not reported | 49 Participants |
| Group 3 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to do a stool test? | Enough | 93 Participants |
| Group 3 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to do a stool test? | Not enough | 106 Participants |
| Group 3 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to do a stool test? | Unknown or not reported | 48 Participants |
| Group 4 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to have a colonoscopy? | Unknown or not reported | 49 Participants |
| Group 4 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to have a colonoscopy? | Not enough | 117 Participants |
| Group 4 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to have a colonoscopy? | Enough | 201 Participants |
| Group 4 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to do a stool test? | Enough | 111 Participants |
| Group 4 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to have a colonoscopy? | Enough | 119 Participants |
| Group 4 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to have a colonoscopy? | Unknown or not reported | 49 Participants |
| Group 4 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to do a stool test? | Unknown or not reported | 50 Participants |
| Group 4 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might not want to do a stool test? | Not enough | 124 Participants |
| Group 4 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to do a stool test? | Not enough | 63 Participants |
| Group 4 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to do a stool test? | Enough | 173 Participants |
| Group 4 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to have a colonoscopy? | Not enough | 35 Participants |
| Group 4 | Number of Participants Who Perceive Being Involved in Shared-Decision Making as Assessed by the Shared Decision Making Process Survey-4 | How much did you and your provider talk about the reasons you might want to do a stool test? | Unknown or not reported | 49 Participants |
Secondary
Number of Participants With Orders for a Colorectal Cancer Screening (CRC) Test
A FIT, colonoscopy, or other CRC screening test ordered within 6 months of each participants' enrollment based on documentation in the electronic health record (EHR).
Time frame: 6 months after patient enrollment
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Group 1 | Number of Participants With Orders for a Colorectal Cancer Screening (CRC) Test | NO order for CRC screening test | 89 Participants |
| Group 1 | Number of Participants With Orders for a Colorectal Cancer Screening (CRC) Test | YES order for CRC screening test | 201 Participants |
| Group 2 | Number of Participants With Orders for a Colorectal Cancer Screening (CRC) Test | YES order for CRC screening test | 178 Participants |
| Group 2 | Number of Participants With Orders for a Colorectal Cancer Screening (CRC) Test | NO order for CRC screening test | 84 Participants |
| Group 3 | Number of Participants With Orders for a Colorectal Cancer Screening (CRC) Test | NO order for CRC screening test | 79 Participants |
| Group 3 | Number of Participants With Orders for a Colorectal Cancer Screening (CRC) Test | YES order for CRC screening test | 168 Participants |
| Group 4 | Number of Participants With Orders for a Colorectal Cancer Screening (CRC) Test | NO order for CRC screening test | 84 Participants |
| Group 4 | Number of Participants With Orders for a Colorectal Cancer Screening (CRC) Test | YES order for CRC screening test | 201 Participants |
Secondary
Number of Providers Who Open Their Provider Notification
Opening the provider notification sent for each patient was assessed by reviewing the electronic health record (EHR).
Time frame: 6 months after patient enrollment
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Group 1 | Number of Providers Who Open Their Provider Notification | Provider notification was opened | 181 Participants |
| Group 1 | Number of Providers Who Open Their Provider Notification | Provider notification was not opened | 34 Participants |
| Group 1 | Number of Providers Who Open Their Provider Notification | Provider notification was not sent | 7 Participants |
| Group 1 | Number of Providers Who Open Their Provider Notification | Unable to determine if provider notification was opened | 68 Participants |
| Group 2 | Number of Providers Who Open Their Provider Notification | Provider notification was not opened | 33 Participants |
| Group 2 | Number of Providers Who Open Their Provider Notification | Provider notification was not sent | 4 Participants |
| Group 2 | Number of Providers Who Open Their Provider Notification | Unable to determine if provider notification was opened | 64 Participants |
| Group 2 | Number of Providers Who Open Their Provider Notification | Provider notification was opened | 161 Participants |
| Group 3 | Number of Providers Who Open Their Provider Notification | Provider notification was not sent | 7 Participants |
| Group 3 | Number of Providers Who Open Their Provider Notification | Provider notification was not opened | 29 Participants |
| Group 3 | Number of Providers Who Open Their Provider Notification | Unable to determine if provider notification was opened | 58 Participants |
| Group 3 | Number of Providers Who Open Their Provider Notification | Provider notification was opened | 153 Participants |
| Group 4 | Number of Providers Who Open Their Provider Notification | Unable to determine if provider notification was opened | 80 Participants |
| Group 4 | Number of Providers Who Open Their Provider Notification | Provider notification was not opened | 28 Participants |
| Group 4 | Number of Providers Who Open Their Provider Notification | Provider notification was opened | 175 Participants |
| Group 4 | Number of Providers Who Open Their Provider Notification | Provider notification was not sent | 2 Participants |
Secondary
Participant's Average Perception of Shared-Decision Making as Assessed by CollaboRATE
A 3-item measure assessing how much effort was made by their provider to: explain colon cancer screening, ask for screening preferences, and incorporate those preferences into the decision. Response options ranged from 0=No effort was made to 9=Every effort was made. The three items were summed and a mean was calculated. Scores can range from 0-9. A higher score indicates more perceived shared decision making. Higher perceived shared decision making is a better outcome.
Time frame: approximately 4-30 days after viewing intervention and 4-14 days after provider visit [post-provider visit/T2]
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Group 1 | Participant's Average Perception of Shared-Decision Making as Assessed by CollaboRATE | 6.4 score on a scale | Standard Deviation 3.1 |
| Group 2 | Participant's Average Perception of Shared-Decision Making as Assessed by CollaboRATE | 6.3 score on a scale | Standard Deviation 3.2 |
| Group 3 | Participant's Average Perception of Shared-Decision Making as Assessed by CollaboRATE | 6.3 score on a scale | Standard Deviation 3.2 |
| Group 4 | Participant's Average Perception of Shared-Decision Making as Assessed by CollaboRATE | 6.5 score on a scale | Standard Deviation 3 |